Skip Navigation

European Heart Journal 1995 16(Supplement C):24-28; doi:10.1093/eurheartj/16.suppl_C.24
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Weber, K. T.
Right arrow Articles by Zhou, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, K. T.
Right arrow Articles by Zhou, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

Myocardial fibrosis in hypertensive heart disease: an overview of potential regulatory machanisms

K. T. Weber, Y. Sun, E. Guarda, L. C. Katwa, A. Ratajska, J. P. M. Cleutjens* and G. Zhou

Division of Cardiology, Department of Internal Medicine, University of Missouri Health Sciences Center Columbia, MO, U.S.A

Correspondence: Karl T.Weber, M.D., University of Missouri Health Sciences Center, Division of Cardiology, Rm. MA432 Medical Science Buildin Coulmbia, MO. 65212. U.S.A.

Myocardial fibrosis in hypertensive heart disease (HHD) can present as a reactive process, involving intramyocardial coronary arteries and arterioles with extensions of collagen into the neighbouring interstitial space, and as a replacement for necrotic cardiac myocytes. Fibrosis adversely affects myocardial stiffness and therefore regulatory mechanisms are of considerable interest. Mechanisms responsible for scarring (reparative fibrosis) are based on factors that adversely influence myocyte survival. This topic is not covered in this brief review. Mechanisms responsible for the perivascular/interstitial fibrosis that appear in both the normotensive, non-hypertrophied right and the pressure overloaded, hypertrophied left ventricle in HHD are addressed herein. They include: (a) angiotensin II (Ang II)- mediated coronary vascular hyperpermeability with subsequent fibrosis; (b) direct hormonal regulation of fibroblast collagen turnover, whereby Ang II, aldosterone an/or endothelins may be involved; (c) autocrine and paracrine signalling between fibroblasts and/or endothelial cells that alters collagen synthesis and degradation and which includes an angiotensin converting enzyme found in fibrous tissue. Collagen turnover in the myocardium is a dynamic process and fibrous tissue is anything but inert.

Key Words: Angiotensin II • aldosterone • endothelin • endothelium • collagen turnover

* Current address: Department of Pathology, University of Limburs, P.O.Box 616, 6200 MD Maastricht. The Netherlands


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.